Bottom line
What is MEDHX's expense ratio?
MEDHX's expense ratio is 0.71%, or about $71 a year on every $10,000 invested. That is cheaper than 76% of emerging-markets bond funds we track (median 0.92%). It has no front-end sales load.
Updated Nov 26, 2025
MEDHX fee table
| Net expense ratio | 0.71% |
|---|---|
| Gross expense ratio | 0.72% |
| Management fee | 0.67% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.05% |
| Fee waiver / reimbursement | -0.01% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What MEDHX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MEDHX | $73 | $229 | $400 | $894 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.71% expense ratio costs roughly $40,300 in lost growth, versus about $51,300 for the median emerging-markets bond fund (0.92%).